Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium versus trihexyphenidyl for pediatric sialorrhea
IRCT20260620069885N1Phase 3Recruiting
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypersalivation comparing Trihexyphenidyl tablets with Ipratropium oral spray (2 arms). Primary endpoint: Drooling Severity and Frequency Scale score. Started Aug 2026; status: recruiting.
02
Drugs
ipratropium bromidetrihexyphenidyl
03
Conditions
hypersalivation
Beyond the preview
Go deeper on IRCT20260620069885N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260620069885N1.